CHICAGO, Sept. 8, 2015 /PRNewswire/ -- The CleoPen is set to break new ground in regenerative medicine, particularly in the areas of scar treatment, fine line and wrinkle reduction, and medical tattooing, among other applications. The device represents the next step in the evolution of collagen induction therapy, a proven technique for encouraging the structural restoration of skin.
Logo - http://photos.prnewswire.com/prnh/20150908/264296LOGO
"We have added The CleoPen to our practice," explains Dr. David Krause of Kankakee, Illinois. "We see the results of collagen induction therapy, and our patients tell us it works. Our office is looking forward to introducing the new technology that The CleoPen has to offer."
The CleoPen distinguishes itself in terms of its versatility and optimization of well-researched, effective aesthetic procedures. The device also allows practitioners to add platelet rich plasma (PRP) therapy to their aesthetic procedure toolset; PRP is a recently developed approach that uses the patient's own blood to synthesize an effective and safe dermal filler.
"Our physician clients are skilled and caring problem solvers," says Rebecca Bell, CEO of RBELL Medical. "We provide hands-on, expert assistance in their quest to provide a better quality of life to their patients. We do so by making an effort to bring additional tools to market and helping physicians navigate the regulatory and product launch process. RBELL Medical is a resource, not just a product."
Swiss-French dermatologist Dr. Phillipe Simonin pioneered the use of collagen induction therapy in 1994, when his study of 600 patients showed significant and dramatic results following just a few treatments. Calling his therapy "Electroridopuncture," the process involved puncturing the skin repeatedly with small needles and thus stimulating the production of new melanin and collagen. Soon, dermatologists and cosmetic surgeons the world over were experimenting with and refining Dr. Simonin's remarkable techniques.
"I enjoy close ties with the regenerative medicine market," adds Bell. "I personally have used collagen induction therapy for skin rejuvenation and scar revision after plastic surgery, and I know it works. But I'm no doctor; so, I asked my own doctors, 'How can I help? What will make these procedures better for you and your patients? What are we missing?' The feedback I received led to the creation of The CleoPen and the RBELL beauty line."
RBELL Medical's vision is to see everyone become the best possible version of themselves. With the company's combination of innovative products and physician training, the world's most sought-after aesthetic procedures are on track to become more convenient and affordable than ever before.
About RBELL MEDICAL LLC
Our mission at RBELL Medical is to improve the care and outcomes of people by becoming the leading source of credible, quality resources. Our focus is to deliver superior service to our providers. CleoPen is a division of RBELL Medical.
Contact:
Rebecca Bell
Email
312-887-0704
SOURCE RBELL Medical LLC
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article